CVS Health stock: RBC set a USD 113.00 target for CVS Health stock
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
RBC Capital has maintained a Buy rating for CVS Health stock and set a USD 113.00 price target. This target is 19.76 percent above the current primary-exchange price. CVS Health is scheduled to report its third-quarter 2026 financial results on November 4, 2026, which will be a key event for investors to assess the analyst's target.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.